$OTLK Up 34%! 🚀 🔹 Outlook Therapeutics ripping after winning its FDA appeal tied to ONS-5010 / LYTENAVA 💥 🔹 FDA now finds substantial evidence of effectiven

$OTLK Up 34%! 🚀 🔹 Outlook Therapeutics ripping after winning its FDA appeal tied to ONS-5010 / LYTENAVA 💥 🔹 FDA now finds substantial evidence of effectiveness for LYTENAVA in wet AMD 👀 🔹 Company plans to resubmit the BLA in June 2026 — major regulatory catalyst back on deck 📅 🔹 Biotech trad…